4/A

FORM 4/A

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: February 5, 2025
Period of Report: January 28, 2025
Accession Number: 0001628280-25-004067

View Document ↗ View on SEC.gov ↗